Page 5 - Quantum Genomics News Today

Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.

Stéphane Cohen joins Quantum Genomics as Director of Global Operations Quantum Genomics , a biopharmaceutical company specializing in the development of a new drug class directly... | March 14, 2022

The trial was neutral but said to have produced important mechanistic insights that could guide the investigational heart failure device therapy to success in the future.

DBMR added a new report titled Heart Failure Drugs Market with data tables for historical and forecast years represented by discussions and graphs spread over pages with easy to understand detailed analysis. The report provides the facts of all the drivers and constraints that are derived from the SWOT analysis. Thi...

Press release Paris, December 6, 2021 Quantum Genomics signs an exclusive license and production agreement with Gulf Pharmaceuticals Industries Julphar. Quantum Genomics will receive up to $20 M

06.12.2021 - Quantum Genomics will receive up to $20 M in upfront, development and sales milestone payments as well as royalties on future salesJulphar will receive an exclusive license to market firibastat in the Middle East, all African countries, Commonwealth ... Seite 1

Quantum Genomics will receive up to $20 M in upfront, development and sales milestone payments as well as royalties on future salesJulphar will receive an...

Gulf Pharmaceutical Industries (Julphar) has announced the signing of an exclusive license and production agreement with Quantum Genomics, a leading biopharmaceutica...

Because initial findings suggest the COVID-19 omicron variant may be less lethal than anticipated, the market is expected to maintain its long-term uptrend. So, we think it could be wise...

For the readers interested in the stock health of Teva Pharmaceutical Industries Limited (TEVA). It is currently valued at $8.44. When the transactions were called off in the previous session, Stock hit the highs of $8.60, after setting-off with the price of $8.55. Company’s stock value dipped to